BMS 250MG 6673
Generic Name: didanosine
Pill imprint BMS 250MG 6673 has been identified as Videx EC 250 mg.
Videx EC is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy.
Videx EC 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Videx EC Images
- Generic Name:
- didanosine
- Imprint:
-
BMS 250MG
6673 - Strength:
- 250 mg
- Color:
- White
- Size:
- 19.00 mm
- Availability:
- Prescription only
- Inactive Ingredients:
- carboxymethylcellulose sodium
diethyl phthalate
methacrylic acid - methyl methacrylate copolymer (1:2)
sodium hydroxide
sodium starch glycolate type A potato
magnesium silicate
gelatin
titanium dioxide
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6673
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5504 | A S Medication Solutions LLC (repackager) |
| 54868-5595 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Videx EC resources
- Videx EC Delayed-Release Enteric-Coated Capsules (Wolters Kluwer)
- Videx EC (Cerner Multum)
- Videx EC (Micromedex) - Includes Dosage Information
- Videx EC (FDA)
Search Again
